AIA
JNJ icon

Acute Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Acute Investment Advisory’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,153
Closed -$205K – 30
2022
Q2 		$205K Buy
+1,153
New +$205K 0.16% 27

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acute Investment Advisory's JNJ Position: Q3 2022 in Review

Acute Investment Advisory sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 1,153 shares — an estimated $205K sold.

Acute Investment Advisory first reported a position in JNJ in Q2 2022 and held it in 1 quarter. The position peaked at $205K in Q2 2022. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Acute Investment Advisory reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • Acute Investment Advisory sold 1,153 Johnson & Johnson shares in Q3 2022, an estimated $205K.
  • Acute Investment Advisory first reported a position in Johnson & Johnson in Q2 2022 and held it in 1 quarter.
  • Acute Investment Advisory's Johnson & Johnson position peaked at $205K in Q2 2022.
  • 3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Acute Investment Advisory's 13F filing for Q3 2022, filed 20 Oct 2022.